
Hand & Wrist
Single intra-articular injection of hylarunon not effective for treatment of first MTPJ OA
This report has been verified
by one or more authors of the
original publication.
Ann Rheum Dis. 2011 Oct;70(10):1838-41. doi: 10.1136/ard.2011.153049. Epub 2011 Jul 25
151 patients with osteoarthritis (OA) of the first metatarsophalangeal joint (MTPJ) were randomized to determine the efficacy of intra-articularly injected hyaluronan for symptomatic treatment of this condition. Patients received a single injection of either Hylan G-F 20 or saline placebo, and were followed for 6 months following the injection. The results indicated that there were no differences between groups in the improvement of pain, foot function and joint stiffness, and demonstrated that a single intra-articular injection of hyaluronan had no beneficial effect in the treatment of first MTPJ OA compared to placebo.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.